ALBANY, N.Y.--(BUSINESS WIRE)--AMRI (NASDAQ:AMRI) announced today that it has initiated a research collaboration with Navigen Pharmaceuticals, Inc. focused on the development of new drug therapies.
ALBANY, N.Y.--(BUSINESS WIRE)--AMRI (NASDAQ:AMRI) announced today that it has initiated a research collaboration with Navigen Pharmaceuticals, Inc. focused on the development of new drug therapies.
